Who is sponsoring NCT03706352?

NCT03706352 is sponsored by King Hussein Cancer Center.

What drugs are being tested in NCT03706352?

Interventions in NCT03706352: tunneling epidural catheter.

What condition does NCT03706352 study?

NCT03706352 studies Epidural Catheter, Post Operative Pain.

Is NCT03706352 still recruiting?

NCT03706352 is currently completed. Last updated 16 October 2018.

Last reviewed 2018-10-16 · How we verify

NCT03706352

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is Tunneling Effective in Preventing Failure of Epidural Analgesia? A Randomized Trial

Completed NA Last updated 16 October 2018

What this trial tests

NA trial testing tunneling epidural catheter in Epidural Catheter in 200 participants. Completed in 13 July 2017.

Timeline

14 April 2015

Primary endpoint
13 July 2017

13 July 2017

Quick facts

Lead sponsor	King Hussein Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	200
Start date	14 April 2015
Primary completion	13 July 2017
Estimated completion	13 July 2017

Drugs / interventions tested

tunneling epidural catheter

Conditions studied

Epidural Catheter — all drugs for Epidural Catheter →
Post Operative Pain — all drugs for Post Operative Pain →

Sponsor

King Hussein Cancer Center — full company profile →

Who can join

Adults 20 to 85, any sex, with Epidural Catheter or Post Operative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective randomized single blinded study in patients planned to undergo general anesthesia and epidural catheter insertion for pain control after abdominal, thoracic and orthopedic surgery. Patients meeting participation criteria will be selected and enrolled sequentially. The study recruitment will be carried out over one year with follow-up for each patient until either the catheter is dislodged or once decided that the patient is to be discontinued from the epidural pain control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other King Hussein Cancer Center trials

Trials by the same sponsor.

NCT07271121 — Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL · Phase 2 · recruiting
NCT06689358 — Thoracic Paravertebral Block for Postoperative Pain Management After VATS · NA · completed
NCT04374903 — Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients · NA · withdrawn
NCT04920513 — Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for · completed
NCT04920656 — Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03706352 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by King Hussein Cancer Center
Last refreshed: 16 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03706352.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing